What is TT's health score?

Trane Technologies plc (TT) has a TradeApes health score of 52 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TT's estimated fair value?

Based on our 5-year discounted cash flow model, Trane Technologies plc's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is TT undervalued or overvalued?

Our model currently rates TT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

Trane Technologies plc (TT)

Healthcare Overvalued low mixed

$480.2

Updated: 2026-07-15

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

60 Healthy

Relative Value

15 Stressed

Capital Allocation

55 Mixed

Risk Management

70 Healthy

Key Findings

+ Strong interest coverage — EBIT covers interest 10×+

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.